HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schroeder, F. Articles by Scallen, T. J. Search for Related Content PubMed PubMed Citation Articles by Schroeder, F. Articles by Scallen, T. J. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 265, Issue 1, 151-157, 01, 1990

Interaction of fluorescent delta 5,7,9(11),22-ergostatetraen-3 beta-ol with sterol carrier protein-2

F Schroeder, P Butko, G Nemecz and TJ Scallen
Department of Pharmacology, College of Pharmacy, University of Cincinnati, Ohio 45267-0004.

The fluorescent sterol delta 5,7,9(11)-dehydroergostatetraen-3 beta-ol (dehydroergosterol) was used as an analogue of cholesterol to examine the molecular interaction of purified rat liver sterol carrier protein- 2 (SCP-2) with sterol. The binding of dehydroergosterol to SCP-2 was evidenced by light scatter and by fluorescence polarization, lifetime, limiting anisotropy, and rotational relaxation time of dehydroergosterol. In addition, energy transfer efficiency from SCP-2 tryptophan to dehydroergosterol was 96%, indicating that the apparent distance, R, between the SCP-2 tryptophan (energy donor) and the dehydroergosterol (energy acceptor) was 13.7 A. Scatchard binding analysis of light scatter, lifetime, and energy transfer data all indicated a 1:1 molar stoichiometry with Kd = 1.2, 1.6, and 1.3 microM, respectively. SCP-2 enhanced the activity of microsomal acyl- CoA:cholesterol acyltransferase through transfer of [3H]cholesterol from donor palmitoyloleoyl phosphatidylcholine/cholesterol small unilamellar vesicles to rat liver microsomes containing the enzyme. A recently developed fluorescence assay utilizing dehydroergosterol fluorescence polarization (Nemecz, G., Fontaine, R. N., and Schroeder, F. (1988) Biochim. Biophys. Acta 948, 511-521; Nemecz, G., and Schroeder, F. (1988) Biochemistry 27, 7740-7749) was applied to examine the effect of SCP-2 on sterol exchange. In the absence of SCP-2, two spontaneously exchangeable sterol domains were observed in palmitoyloleoyl phosphatidylcholine/sterol (65:35 molar ratio) small unilamellar vesicles. SCP-2 enhanced the rate of exchange of the faster exchanging domain 2-fold. The transfer rate of the more slowly exchangeable sterol domain and the fraction of cholesterol represented by each domain were not affected. These results demonstrate the utility of dehydroergosterol to probe SCP-2 interactions with sterols and are indicative of a physiological role for SCP-2 as a soluble sterol carrier.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. M. B. B. Estronca, M. J. Moreno, and W. L. C. Vaz Kinetics and Thermodynamics of the Association of Dehydroergosterol with Lipid Bilayer Membranes Biophys. J., December 15, 2007; 93(12): 4244 - 4253. [Abstract] [Full Text] [PDF]

				B. P. Atshaves, S. M. Storey, and F. Schroeder Sterol carrier protein-2/sterol carrier protein-x expression differentially alters fatty acid metabolism in L cell fibroblasts J. Lipid Res., September 1, 2003; 44(9): 1751 - 1762. [Abstract] [Full Text] [PDF]

				N. Friedland, H.-L. Liou, P. Lobel, and A. M. Stock Structure of a cholesterol-binding protein deficient in Niemann-Pick type C2 disease PNAS, March 4, 2003; 100(5): 2512 - 2517. [Abstract] [Full Text] [PDF]

				B. P. Atshaves, S. M. Storey, A. Petrescu, C. C. Greenberg, O. I. Lyuksyutova, R. Smith III, and F. Schroeder Expression of fatty acid binding proteins inhibits lipid accumulation and alters toxicity in L cell fibroblasts Am J Physiol Cell Physiol, September 1, 2002; 283(3): C688 - C703. [Abstract] [Full Text] [PDF]

				M. Fuchs, A. Hafer, C. Munch, F. Kannenberg, S. Teichmann, J. Scheibner, E. F. Stange, and U. Seedorf Disruption of the Sterol Carrier Protein 2 Gene in Mice Impairs Biliary Lipid and Hepatic Cholesterol Metabolism J. Biol. Chem., December 14, 2001; 276(51): 48058 - 48065. [Abstract] [Full Text] [PDF]

				O. Starodub, C. A. Jolly, B. P. Atshaves, J. B. Roths, E. J. Murphy, A. B. Kier, and F. Schroeder Sterol carrier protein-2 localization in endoplasmic reticulum and role in phospholipid formation Am J Physiol Cell Physiol, October 1, 2000; 279(4): C1259 - C1269. [Abstract] [Full Text] [PDF]

				N. Stolowich, A. Frolov, A. D. Petrescu, A. I. Scott, J. T. Billheimer, and F. Schroeder Holo-sterol Carrier Protein-2. 13C NMR INVESTIGATION OF CHOLESTEROL AND FATTY ACID BINDING SITES J. Biol. Chem., December 10, 1999; 274(50): 35425 - 35433. [Abstract] [Full Text] [PDF]

				B. P. Atshaves, A. D. Petrescu, O. Starodub, J. B. Roths, A. B. Kier, and F. Schroeder Expression and intracellular processing of the 58 kDa sterol carrier protein-2/3-oxoacyl-CoA thiolase in transfected mouse L-cell fibroblasts J. Lipid Res., April 1, 1999; 40(4): 610 - 622. [Abstract] [Full Text]

				B. P. Atshaves, O. Starodub, A. McIntosh, A. Petrescu, J. B. Roths, A. B. Kier, and F. Schroeder Sterol Carrier Protein-2 Alters High Density Lipoprotein-mediated Cholesterol Efflux J. Biol. Chem., November 17, 2000; 275(47): 36852 - 36861. [Abstract] [Full Text] [PDF]

				A. D. Petrescu, A. M. Gallegos, Y. Okamura, J. F. Strauss III, and F. Schroeder Steroidogenic Acute Regulatory Protein Binds Cholesterol and Modulates Mitochondrial Membrane Sterol Domain Dynamics J. Biol. Chem., September 28, 2001; 276(40): 36970 - 36982. [Abstract] [Full Text] [PDF]